Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1 1

Status

Recruiting 13Active not recruiting 11Not yet recruiting 7Withdrawn 1

Sponsor Class

OTHER 7

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1CNS 1

Conditions

Breast Neoplasms 355Neoplasms 252Carcinoma, Non-Small-Cell Lung 199Colorectal Neoplasms 181Lung Neoplasms 151Prostatic Neoplasms 150Carcinoma, Hepatocellular 127Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 82Neoplasm Metastasis 73Recurrence 72Uterine Cervical Neoplasms 68Rectal Neoplasms 68Ovarian Neoplasms 65Stomach Neoplasms 64Triple Negative Breast Neoplasms 59Squamous Cell Carcinoma of Head and Neck 57Brain Neoplasms 56Head and Neck Neoplasms 55Glioblastoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 48Melanoma 45Endometrial Neoplasms 43Disease 43Esophageal Neoplasms 42Hematologic Neoplasms 41Glioma 41Colonic Neoplasms 41

Interventions

pembrolizumab 1XELOX 1Nivolumab 1Ipilimumab 1Induction Chemotherapy 1Immunotherapy 1DNA Mismatch Repair 1DEAE-Dextran 1Colonoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Not yet recruiting × Turcot syndrome × 1 year × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

NCT07403877 2026-02-11

TORCH-OPTIMA

Fudan University

Phase 2 Not yet recruiting
114 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT07385846 2026-02-04

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

University of Cincinnati

Phase 1 Not yet recruiting
8 enrolled
CNS

Turcot syndrome, Glioblastoma

NCT07266025 2026-01-27

CATALIS

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
30 enrolled

Turcot syndrome

NCT07369986 2026-01-27

IMMUNE-SAVE

Women's Hospital School Of Medicine Zhejiang University

Phase 2 Not yet recruiting
30 enrolled
Gynecologic

Turcot syndrome, Endometrial Neoplasms

NCT07360834 2026-01-23

PREDI-LYNCH

UNICANCER

Phase NA Not yet recruiting
2,000 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT07259473 2026-01-07

Pre-CATALIS

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
15 enrolled

Turcot syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡